Trump bought as much as $5 million in Axon stock before ICE sought $220 million Taser deal

President Donald Trump made a significant stock purchase of Axon Enterprise, the company behind Tasers and policing software, investing between $1 million and $5 million just two weeks before Immigration and Customs Enforcement (ICE) sought a $220 million contract for new Tasers. This contract, which experts suggest was tailored for Axon, was announced on February 24, shortly after Trump's stock acquisition on February 10. Federal disclosures released in May revealed Trump's stock purchase, which has sparked scrutiny regarding potential conflicts of interest. A spokesperson for Trump stated that his assets are managed by a trust run by his children and that independent firms handle his investments. They dismissed concerns as politically motivated, labeling them a 'tired narrative'. The ICE notice did not explicitly mention Axon but sought approximately 17,800 Tasers along with related equipment, aligning closely with Axon's offerings. Procurement experts noted that the specifications provided in the ICE notice matched only Axon’s products, which dominate the U.S. Taser market. If the deal is finalized, it would significantly expand ICE's Taser inventory by replacing about 4,300 devices. However, there is no evidence that Trump was involved in the procurement process or that Axon was aware of his investment at the time of the contract notice. Ethics experts have raised alarms over the timing of Trump's stock purchase and ICE's solicitation, as it coincides with the president's push for increased immigration enforcement. Critics argue that purchasing stock in a company affected by one's own policy decisions raises serious ethical concerns, although there is no proof of wrongdoing. Axon’s stock experienced substantial growth following Trump's purchase, suggesting potential financial benefits for the company amid the heightened demand for its products. The company's revenue from federal contracts has surged, with Axon recently reporting record earnings driven by Taser sales and its expanding AI product line. As ICE considers expanding its procurement, the implications of such contracts extend beyond Tasers, potentially establishing long-lasting partnerships with Axon for various policing technologies. Critics warn that this could deepen ICE's integration into Axon's surveillance ecosystem, raising further questions about civil liberties and accountability in law enforcement practices. In light of these developments, Axon has increased its lobbying efforts in Washington, with significant spending aimed at influencing legislation related to policing technology. The company’s strategic positioning suggests that it stands to gain considerably from the growing demand for law enforcement tools, highlighting the intricate relationship between government contracts and private sector interests.